Target intelligence / Profile preview

RNA, U6 small nuclear 460, pseudogene (RNU6-460P)

Target
RNU6-460P
Molecular classification
Other (pseudogene), Does not belong to families like receptor, enzyme, ion channel, transporter, or transcription factor
01

Overview

RNU6-460P (RNA, U6 small nuclear 460, pseudogene) is a genomic sequence derived from the U6 snRNA gene family, classified as a pseudogene. The U6 snRNA gene encodes a highly conserved small nuclear RNA component essential for the spliceosome, a complex responsible for mediating pre-mRNA splicing in eukaryotic nuclei[5][4]. Pseudogenes like RNU6-460P result from duplication or retrotransposition events involving functional U6 snRNA genes, but they typically lack regulatory sequences or functional coding capacity, rendering them biologically inert in terms of transcription or participation in molecular pathways[1]. RNU6-460P is annotated in genomic databases as a pseudogene, without known involvement in cellular signaling, disease processes, or drug interactions. If you require structured information about functional U6 snRNA, see: - canonical_name: U6 small nuclear RNA - molecular_classification: Small nuclear RNA (snRNA), component of spliceosome - biological_functions: mRNA splicing, spliceosome assembly and catalysis[5][4]. - disease_roles: Indirectly, defects in snRNA processing can contribute to splicing disorders, though no known direct role for RNU6-460P pseudogene. Note: RNU6-460P should not be considered a primary molecular target for drug discovery, diagnostics, or therapeutic intervention. For spliceosome function, refer to active U6 small nuclear RNA.

Other names
RNU6-460PRNA, U6 small nuclear 460, pseudogeneU6 snRNA pseudogene 460

Beyond the preview

Go deeper on RNA, U6 small nuclear 460, pseudogene (RNU6-460P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 460, pseudogene (RNU6-460P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call